Status:

TERMINATED

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

Lead Sponsor:

Obstetrix Medical Group

Conditions:

Hydrops Fetalis

Fetal Growth Retardation

Eligibility:

FEMALE

18-60 years

Brief Summary

The objective of this pilot study is to prospectively evaluate amniotic fluid of pregnancies complicated by non-immune hydrops and severe symmetrical intrauterine growth restriction by tandem mass spe...

Detailed Description

Nonimmune hydrops (NIH) and severe symmetrical intrauterine growth restriction (IUGR) represent two obstetrical circumstances that occur with relative frequency yet often escape adequate etiology asse...

Eligibility Criteria

Inclusion

  • NIH
  • Singleton gestation
  • 18 years of age or older
  • Excess extracellular fluid in at least two fetal sites as noted by ultrasound: abdomen (ascites), the chest (pleural and pericardial effusions), the skin (edema \> 5mm), the amniotic cavity (polyhydramnios), and the placenta (thickening \> 6cm)
  • NIH diagnosis \> 15w0d gestation
  • Diagnostic amniocentesis performed at \> 15w0d gestation
  • NIH

Exclusion

  • Immune-mediated hydrops fetalis as diagnosed by maternal red cell antigens and fetal anemia suspected by middle cerebral artery doppler ultrasound and/or confirmed by percutaneous umbilical blood sampling
  • Structural anomaly identified by ultrasound
  • Chromosomal aneuploidy
  • Multiple gestations
  • IUGR Inclusion Criteria:
  • Singleton gestation
  • 18 years of age or older
  • Severe symmetrical IUGR defined as a \> 3 week lag of all fetal ultrasound measurements (biparietal diameter, head circumference, abdominal circumference, and femur length)
  • IUGR diagnosis between 24-32 weeks gestation
  • Diagnostic amniocentesis performed prior to 32 weeks gestation
  • IUGR

Key Trial Info

Start Date :

March 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00143039

Start Date

March 1 2006

End Date

August 1 2009

Last Update

December 19 2014

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Banner Good Sammaritan Hospital

Phoenix, Arizona, United States, 85006

2

Banner Desert Samaritan Hospital

Phoenix, Arizona, United States, 85202

3

Saddleback Memorial Medical Center

Laguna Hills, California, United States, 92653

4

Long Beach Memorial Medical Center

Long Beach, California, United States, 90801-1428